Ожирение и метаболизм

Расширенный поиск

Критерий диагностики досимптоматической(преморбидной) стадии метаболического синдрома

Полный текст:

Список литературы

1. Генетический паспорт - основа индивидуальной и предиктивной медицины / Под ред. В.С.Баранова. СПб.: Изд-во Н.Л., 2009: 528 с.

2. Дедов И.И., Мельниченко Г.А., Бутрова С.А. Жировая ткань как эндокринный орган (обзор литературы) // Ожирение и метаболизм 2006; 1 (6): 6-13.

3. Advanced glycation end-products: a review. R. Singh, A. Barden, T. Mori [et al.] // Diabetologia 2001; 44 (2): 129-146.

4. Altman D.G. Statistics Notes: tests 1: sensitivity and specificity [Электронный ресурс]. D.G. Altman, J.M. Bland // BMJ 1994; 308: 1552. http : // bmj.bmjjournals. com/cgi/content/full/308/6943/1552.

5. Bays H.E. Adiposopathy is a more rational treatment target for metabolic dis-ease than obesity alone // Curr. Atheroscler. 2006; 8: 144-156.

6. Components of the «metabolic syndrome» and incidence of type 2 diabetes. R.L. Hanson, G. Imperatore, P.H. Bennett [et al.] // Diabetes 2002; 51: 3120-3127.

7. Ford E.S. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. E.S. Ford, W.H. Giles, W.H. Dietz // JAMA 2002; 287: 356-359.

8. Ford E.S. Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome // Diabetes Care 2005; 28: 1769-1778.

9. Schmidt M.I., Duncan B.B., Bang H. et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study // Diabetes Care 2005; 8: 2013-2018.

10. Ingelsson E., Sundstrцm J., Arnlцv J. Insulin resistance and risk of congestive heart failure // JAMA 2005; 20 (294): 334-341.

11. Jolliffe C.J., Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and Interna-tional Diabetes Federation criteria // J. Am. Coll. Cardiol. 2007; 49: 891-898.

12. Kenchaiah S. Body mass index and vigorous physical activity and the risk of heart failure among men. S. Kenchaiah, H.D. Sesso, J.M. Gaziano // Circulation 2009; 119 (1): 4452.

13. Mancia G., Bombelli M., Corrao G. et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis // Hypertension 2007; 49: 40-47.

14. Eberly L.E., Prineas R., Cohen J.D. et al. Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial // Diabetes Care 2006; 29(1): 123-130.

15. Pietrobelli A., Miller S., Tan Y.X., Nu-ez C., Heymsfield S.B. Phenotyping obese subjects: multi-contact electrode bioimpedance system for practical body composition measurement // Experimental Biology 1999; 3: 68-76.

16. Vasan R.S., Beiser A., Seshadri S. et al. Residual lifetime risk for developing hypertension in middle-aged women and men. The Framingham Heart Study // JAMA 2002; 287: 1003-1010.


Для цитирования:

Dmitriev A.N., Perminova L.R. Критерий диагностики досимптоматической(преморбидной) стадии метаболического синдрома. Ожирение и метаболизм. 2010;7(4):24-28.

For citation:

., . Kriteriy diagnostiki dosimptomaticheskoy(premorbidnoy) stadii metabolicheskogo sindroma. Obesity and metabolism. 2010;7(4):24-28. (In Russ.)

Просмотров: 311

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)